CMFRI, Library (2019) Seaweed product to combat Blood Pressure Deccan Chronicle dated 29th May 2019. Deccan Chronicle.
|
Text
Deccan Chronicle_29-05-2019.pdf Download (174kB) | Preview |
Abstract
In a major development, the Central Marine Fisheries Research Institute (CMFRI) here has come up with a nutraceutical product from seaweeds to combat hypertension. The product, CadalminTM Antihypertensive extract (CadalminTM AHe), is developed from medicinal seaweeds commonly present in the Indian coastal waters. Bioactive pharmacophore leads from seaweeds have been used to develop the product which can be administered orally to regulate hypertension that is one of the risk factors for strokes, heart attacks, heart failure, and arterial aneurysm, and is a leading cause of chronic kidney failure. This is sixth in the series of the nutraceutical products developed by CMFRI. The institute had developed and commercialised natural products for diseases such as diabetes, arthritis, cholesterol and hypothyroid.
| Item Type: | Other |
|---|---|
| Uncontrolled Keywords: | Newspaper; News; CMFRI in Media |
| Subjects: | CMFRI News Clippings |
| Divisions: | Library and Documentation Centre |
| Depositing User: | Arun Surendran |
| Date Deposited: | 27 Jul 2019 06:52 |
| Last Modified: | 13 Aug 2019 08:05 |
| URI: | http://eprints.cmfri.org.in/id/eprint/13723 |
Actions (login required)
 |
View Item |
